FourPoints Investment Managers’s Gilead Sciences GILD Stock Holding History

FourPoints Investment Managers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.37M	Sell	20,200 -6,400	-24%	-$450K	1.43%	38
2016 Q4	$1.91M	Hold	26,600	–	–	1.69%	36
2016 Q3	$2.1M	Sell	26,600 -3,900	-13%	-$317K	1.6%	30
2016 Q2	$2.54M	Buy	30,500 +900	+3%	+$79.9K	1.78%	29
2016 Q1	$2.72M	Sell	29,600 -3,800	-11%	-$343K	1.69%	29
2015 Q4	$3.38M	Buy	33,400 +17,400	+109%	+$1.81M	1.43%	29
2015 Q3	$1.57M	Buy	+16,000	New	+$1.78M	0.63%	48
2013 Q4	–	Sell	-5,481	Closed	-$344K	–	82
2013 Q3	$344K	Sell	5,481 -209	-4%	-$12.5K	0.03%	84
2013 Q2	$291K	Buy	+5,690	New	+$297K	0.03%	84

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

FourPoints Investment Managers's GILD Position: Q1 2017 in Review

FourPoints Investment Managers reduced its Gilead Sciences (GILD) stake by 24% in Q1 2017, selling an estimated $450K and leaving 20,200 shares worth $1.37M. The position accounts for 1.43% of the portfolio, ranked #38.

FourPoints Investment Managers first reported a position in GILD in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.38M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

FourPoints Investment Managers held 20,200 shares of Gilead Sciences worth $1.37M as of Q1 2017.
FourPoints Investment Managers sold 6,400 Gilead Sciences shares in Q1 2017, an estimated $450K.
Gilead Sciences made up 1.43% of FourPoints Investment Managers's portfolio in Q1 2017, its #38 holding.
FourPoints Investment Managers first reported a position in Gilead Sciences in Q2 2013 and has held it in 9 quarters since.
FourPoints Investment Managers's Gilead Sciences position peaked at $3.38M in Q4 2015.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on FourPoints Investment Managers's 13F filing for Q1 2017, filed 15 May 2017.